Cencora, Inc. $COR Shares Purchased by Capital Wealth Planning LLC

Capital Wealth Planning LLC lifted its holdings in Cencora, Inc. (NYSE:CORFree Report) by 74.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,097 shares of the company’s stock after purchasing an additional 10,746 shares during the quarter. Capital Wealth Planning LLC’s holdings in Cencora were worth $8,477,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Oakworth Capital Inc. acquired a new position in shares of Cencora during the fourth quarter valued at $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora during the fourth quarter valued at $27,000. Archer Investment Corp increased its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of Cencora during the third quarter valued at $30,000. Finally, Caitlin John LLC acquired a new position in shares of Cencora during the third quarter valued at $31,000. 97.52% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on COR shares. Barclays lowered their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday. Wells Fargo & Company lowered their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. UBS Group raised their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. William Blair started coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating on the stock. Finally, Citigroup lowered their price target on Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $374.00.

Get Our Latest Analysis on Cencora

Cencora Trading Up 0.7%

Shares of COR stock opened at $281.48 on Thursday. The stock has a 50-day simple moving average of $290.59 and a 200 day simple moving average of $328.55. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The stock has a market capitalization of $54.76 billion, a P/E ratio of 21.59, a P/E/G ratio of 1.51 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:CORGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the prior year, the business earned $4.42 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora declared that its Board of Directors has authorized a stock buyback plan on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora Company Profile

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

Featured Articles

Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:CORFree Report).

Institutional Ownership by Quarter for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.